Skip to main content

Table 4 Immunohistochemical staining density of different study groups

From: MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II

Antibody

Control (I)

PDAC w CTX

PDAC w/o CTX

p

Good response (II)

Bad response (III)

PTEN

     

+4

3

1

0

0

I vs. II: 0.0901

+3

6

7

6

0

I vs. III: 0.0003

+2

4

14

16

12

II vs. III: 0.0394

+1

0

3

17

15

 

DCK

     

+4

7

10

6

1

I vs. II: 0.7549

+3

4

8

13

16

I vs. III: 0.0287

+2

2

6

15

9

II vs. III: 0.1147

+1

0

1

5

1

 

HuR

     

+4

0

0

0

0

I vs. II: 0.0687

+3

5

2

3

1

I vs. III: 0.0137

+2

5

13

13

8

II vs. III: 0.3054

+1

3

10

23

18

 

MDR-1

     

+4

0

0

0

0

I vs. II: 0.7427

+3

0

1

7

1

I vs. III: 0.1068

+2

2

3

11

5

II vs. III: 0.0426

+1

11

21

21

21

 

MRP-1

     

+4

9

1

4

1

I vs. II: 0.00001

+3

4

3

12

3

I vs. III: 0.0001

+2

0

6

11

10

II vs. III: 0.1005

+1

0

15

12

13

 

BCRP-1

     

+4

2

0

0

0

I vs. II: 0.00003

+3

8

1

7

2

I vs. III: 0.0005

+2

3

12

24

19

II vs. III: 0.0378

+1

0

12

8

6

 

VEGF-1

     

+4

10

0

1

0

I vs. II: <0.0001

+3

3

4

6

2

I vs. III: <0.0001

+2

0

14

23

12

II vs. III: 0.8456

+1

0

7

9

13

 
  1. p < 0.05 indicates significance